India  

Bharat Biotech expects COVID-19 vaccine to be atleast 60% effective, launch likely in Q2 of 2021

DNA Sunday, 22 November 2020
Bharat Biotech launched its third phase trials of Covaxin in Haryana on November 20. It had applied for permission to the DGCI on October 2
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: 'Covaxin phase-3 trial probably largest clinical trial in India': Principal Investigator

'Covaxin phase-3 trial probably largest clinical trial in India': Principal Investigator 01:36

Phase-3 trial of Covaxin is very crucial, and this is the largest clinically phase-3 trial in India, said Dr. E Venkata Rao, Principal Investigator in the Covaxin human trial to ANI on November 21. He said, "After the success of Phase-1 and 2 of this indigenously developed vaccine by Bharat Biotech....

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the..
IndiaTimes
TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).

Credit: ANI    Duration: 01:28Published

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Haryana Haryana State in northern India

Delhi to shiver again at 4 degrees Celsius [Video]

Delhi to shiver again at 4 degrees Celsius

Moderate fog engulfed the national capital on the morning of January 24. Bitter cold conditions prevail in parts of north India. Minimum temperature of 4 degrees Celsius is expected in the upcoming week in Delhi. According to the India Meteorological Department, cold wave to severe cold wave is predicted in isolated pockets of Delhi for next 2-3 days. Northern Indian states including the Himalayas can likely to witness rain, thunderstorm and snow during the next few days. IMD's regional Met centre in New Delhi has issued orange alerts over Uttar Pradesh for Jan 24 and across Punjab, Haryana, Chandigarh, and Delhi for Jan 24 and 25.

Credit: ANI    Duration: 01:00Published

IMD predicts cold wave conditions over North India for next 3-4 days

Punjab, Haryana, Chandigarh, Delhi and Uttar Pradesh can witness cold to severe cold waves during January 26 to January 27.
DNA
Watch: Scuffle between farmers, Uttarakhand Police [Video]

Watch: Scuffle between farmers, Uttarakhand Police

A scuffle broke out between protesting farmers and officials of Uttarakhand Police on Haridwar-Dehradun Road in Lachhiwala on Jan 23 after the latter tried to stop them from marching towards the Raj Bhavan. Farmers in several states, mainly from Punjab and Haryana, are protesting against the three agricultural laws for nearly two months.

Credit: ANI    Duration: 01:40Published

You Might Like


Related videos from verified sources

Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin [Video]

Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin

Haryana Health Minister Anil Vij was administered a trial dose of Covaxin on Friday. 67-year old Vij was administered the trial dose at the Civil Hospital at Ambala Cantt. On Wednesday, Vij had said..

Credit: HT Digital Content     Duration: 01:43Published
Haryana Health Minister Anil Vij becomes the 1st volunteer of Covid vaccine in Haryana|Oneindia News [Video]

Haryana Health Minister Anil Vij becomes the 1st volunteer of Covid vaccine in Haryana|Oneindia News

Haryana Health Minister Anil Vij has become the first volunteer of the Covaxin in his state of Haryana. He was administered a trial dose of a coronavirus vaccine today in a hospital in the state's..

Credit: Oneindia     Duration: 01:00Published
‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C [Video]

‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C

The third-phase trial of Bharat Biotech's Covid-19 vaccine candidate, Covaxin will begin from November 20. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes..

Credit: HT Digital Content     Duration: 02:29Published